| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | Reported by Park Avenue Institutional Advisers LLC, Park Avenue Securities LLC | 13F-NT | 8/4/2026 | 000119312526331700 | ||
| Q1 2026 | Reported by Park Avenue Institutional Advisers LLC | 13F-NT | 5/5/2026 | 000119312526206737 | ||
| Q4 2025 | Reported by Park Avenue Institutional Advisers LLC | 13F-NT | 2/10/2026 | 000119312526044420 | ||
| Q3 2025 | Reported by Park Avenue Institutional Advisers LLC | 13F-NT | 10/30/2025 | 000119312525258421 | ||
| Q2 2025 | Reported by Park Avenue Institutional Advisers LLC, Alliance Bernstein | 13F-NT | 7/31/2025 | 000095012325006849 | ||
| Q1 2025 | Reported by Park Avenue Institutional Advisers LLC, Alliance Bernstein | 13F-NT | 5/6/2025 | 000095012325004104 | ||
| Q4 2024 | Reported by Victory Capital Management Inc | 13F-NT | 2/7/2025 | 000095012325001149 | ||
| Q3 2024 | Reported by Victory Capital Management Inc | 13F-NT | 11/4/2024 | 000095012324010326 | ||
| Q2 2024 | Reported by Victory Capital Management Inc | 13F-NT | 8/5/2024 | 000095012324007120 | ||
| Q1 2024 | 1 | 199 | COIN | 13F-HR | 5/7/2024 | 000095012324003976 |
| Q4 2023 | Reported by Victory Capital Management Inc | 13F-NT | 2/2/2024 | 000095012324000640 | ||
| Q3 2021 | 3 | 209,796 | LQD, DKNG, OLO | RESTATEMENT | 11/16/2021 | 000095012321015677 |
| Q2 2021 | 1 | 0 | 13F-HR | 8/13/2021 | 000095012321010823 | |
| Q1 2021 | 1 | 202,228 | LQD | 13F-HR | 5/14/2021 | 000095012321006503 |
| Q4 2020 | 1 | 214,792 | LQD | 13F-HR | 2/12/2021 | 000095012321001880 |
| Q3 2020 | 13F-HR | 11/13/2020 | 000095012320011701 | |||
| Q2 2020 | 13F-HR | 7/31/2020 | 000095012320007393 | |||
| Q1 2020 | 1 | 0 | 13F-HR | 5/14/2020 | 000095012320004814 | |
| Q4 2019 | 514 | 422,609 | IWF, EFA, IWN, IWS | 13F-HR | 2/11/2020 | 000095012320001416 |
| Q3 2019 | 528 | 668,380 | IWD, LQD, GLD, EFA | 13F-HR | 11/12/2019 | 000095012319010595 |
| Q2 2019 | 530 | 724,528 | IWD, LQD, GLD, EFA | 13F-HR | 8/12/2019 | 000095012319007590 |
| Q1 2019 | 528 | 787,635 | LQD, IWD, EFA, GLD | 13F-HR | 5/14/2019 | 000095012319004883 |
| Q4 2018 | 525 | 578,886 | IWD, GLD, SPY, EFA | 13F-HR | 2/6/2019 | 000095012319000732 |
| Q3 2018 | 524 | 612,602 | IWD, GLD, EFA, IWN | 13F-HR | 11/14/2018 | 000095012318011651 |
| Q2 2018 | 523 | 590,825 | IWD, GLD, EFA, IWN | 13F-HR | 8/10/2018 | 000095012318007861 |
| Q1 2018 | 523 | 541,953 | IWD, GLD, EFA, IAU | 13F-HR | 5/10/2018 | 000095012318004618 |
| Q4 2017 | 527 | 457,313 | IWD, GLD, DBA, IWM | 13F-HR | 2/14/2018 | 000095012318002171 |
| Q3 2017 | 522 | 649,761 | HYG, LQD, IWD, GLD | 13F-HR | 11/14/2017 | 000095012317010678 |
| Q2 2017 | 514 | 686,385 | EEM, DBE, GLD, SLV | 13F-HR | 8/14/2017 | 000095012317007939 |
| Q1 2017 | 527 | 691,943 | LQD, HYG, GLD, DBA | 13F-HR | 5/12/2017 | 000095012317004749 |
| Q4 2016 | 537 | 677,237 | HYG, LQD, IWR, IWM | 13F-HR | 2/14/2017 | 000095012317002289 |
| Q3 2016 | 566 | 1,088,272 | HYG, LQD, IWR, EFA | 13F-HR | 11/14/2016 | 000095012316022184 |
| Q2 2016 | 586 | 1,286,421 | HYG, LQD, IWR, ARES CAP CORP | 13F-HR | 8/15/2016 | 000095012316020023 |
| Q1 2016 | 583 | 1,138,184 | HYG, IWR, EFA, IWM | 13F-HR | 5/12/2016 | 000095012316016917 |
| Q4 2015 | 575 | 990,148 | HYG, IWR, IWM, GILEAD SCIENCES INC | RESTATEMENT | 2/12/2016 | 000164080116000012 |
| Q3 2015 | 577 | 984,364 | SPY, IWR, IWM, GLD | 13F-HR | 11/12/2015 | 000164080115000008 |
| Q2 2015 | 575 | 1,153,880 | JARDEN CORP, IWM, IWR, GILEAD SCIENCES INC | RESTATEMENT | 8/14/2015 | 000164080115000005 |
| Q1 2015 | 581 | 1,056,383 | IWM, IWR, GILEAD SCIENCES INC, DBA | 13F-HR | 5/5/2015 | 000072857215000006 |
| Q4 2014 | 581 | 982,982 | DBA, GILEAD SCIENCES INC, EEM, PRICELINECOM INC | 13F-HR | 2/12/2015 | 000072857215000002 |
| Q3 2014 | 577 | 983,068 | DBA, GILEAD SCIENCES INC, PRICELINECOM INC, GLD | 13F-HR | 11/6/2014 | 000072857214000014 |
| Q2 2014 | 570 | 1,040,187 | DBA, IWM, EFA, GILEAD SCIENCES INC | 13F-HR | 8/13/2014 | 000072857214000012 |
| Q1 2014 | 581 | 1,125,701 | DBA, IWM, GILEAD SCIENCES INC, THE PRICELINE GROUP INC | 13F-HR | 5/14/2014 | 000072857214000008 |
| Q4 2013 | 581 | 1,092,667 | DBA, IWM, GILEAD SCIENCES INC, PRICELINECOM INC | 13F-HR | 2/11/2014 | 000072857214000004 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G.
2 securities where the latest filing since 12/18/2024 is a 13G, the newest filed 11/7/2025. View all